Miles Vorkosigan’s post-cryo-revival seizure disorder

Miles Vorkosigan’s post-cryo-revival seizure disorder turns survival into an ongoing medical and practical problem: the Cryo-revival that restored him after a Needle grenade attack left him vulnerable to attacks that can interrupt consciousness and control. The condition constrains his movement and prospects for service, revives the memory of the death that preceded it, and ultimately leads him to accept an experimental device that would let him trigger an attack under controlled conditions.

Onset and immediate consequences

When Miles explains his condition to Martin Kosti, he links it directly to the Needle grenade that killed him and to his subsequent Cryo-revival. The revival, he says, almost worked; the seizures are the lingering consequence. The disclosure matters practically as well as medically: he cannot drive himself, and he needs Martin to live in as a driver and to be available when required. Rather than let his new employee discover the condition during an attack, Miles chooses to warn him, even though the disclosure means explaining that he had been dead.

The risk follows Miles beyond the household. On the journey through Vorkosigan’s District, Martin pilots the lightflyer while Miles observes that its fail-safe systems make it almost impossible to crash. A five-minute seizure, however, could still defeat those safeguards. At Vorkosigan Surleau, the same uncertainty reaches into the pastimes that once made the estate restorative. Miles wonders whether he can ride his twenty-three-year-old horse, Fat Ninny, even for a turn around the pasture, and whether Martin could act as a spotter. Swimming is out; sailing would mean wearing a life jacket and relying on Martin to manage both a boat and a possible emergency. These are not abstract restrictions: the disorder makes familiar pleasures contingent on supervision and risk.

Service, fear, and the meaning of discharge

The seizures complicate Miles’s military future, but they are not the stated reason he was dismissed from ImpSec. He tells Ivan Vorpatril that he was removed for falsifying a report, a serious breach that would remain even if doctors restored him to perfect working order. Miles believes Simon Illyan cannot take him back without abandoning a matter of principle. The distinction leaves him facing two obstacles at once: a medical condition that makes command unsafe and a professional rupture that treatment alone cannot repair.

Gregor also asks Miles not to make independent contact with the Dendarii Free Mercenary Armada. Miles recognizes that taking command again could expose him to a treason charge, and agrees that the Dendarii do not need a commander who may convulse. For now, he calls the temptation to return null, while asking what will become of the fleet under Elli Quinn. He argues that it can remain an Imperial resource under her command. His illness therefore changes not only what he can personally do, but also how he imagines the future of an organization he built.

Yet Miles is not certain that the medical condition alone explains his departure from danger. He remembers the Needle grenade’s impact as a flash of his chest bursting open, followed by pain that continued for weeks after he woke. He had returned to duty after the later Vorberg injury and believed he was doing all right until the seizures began. He then considers whether the chain from seizure to falsified report to discharge may have become a way to avoid facing another Needle grenade launcher without openly admitting that he wanted to quit. The disorder sits beside a more difficult question: whether his exit was imposed by incapacity, shaped by fear, or entangled with both.

A biochemical explanation

On the sixth day of the medical investigation, an Imperial Service cryonicist and neurologist finally provoke one of Miles’s seizures in the laboratory. He wakes amid his familiar colored confetti and darkness, still on an examination table, his head enclosed in a large scanner and his body wired to monitors. The doctors are absorbed in the readings before they turn their attention to him. Their excitement marks a reversal: what Miles experiences as a disabling attack is also a rare diagnostic event for the specialists.

Dr. Chenko explains that after Cryo-revival, Miles’s brain began producing unusually high levels of neurotransmitters. These accumulate in neural reservoirs; stress or excitement can trigger a sudden cascade release. Normal neural functions temporarily shut down, accounting for the hallucinations Miles reports. After a minute or two, the reservoirs empty to below-normal levels, producing the subsequent period of unconsciousness. As equilibrium returns, Miles regains consciousness in a fatigued state, and the cycle can begin again. The attacks are thus biochemical rather than phase-electrical epilepsy, and the abnormality is widespread through the brain, though concentrated in the frontal lobes rather than the brain stem. That concentration means the attacks do not kill him outright, but the broader distribution makes an obvious surgical remedy unavailable.

Treatment and a controlled attack

Medication offers little prospect of eliminating the seizures. Miles appears to overproduce dozens, perhaps hundreds, or even all of the relevant chemicals; suppressing them together is not feasible, and reducing their production would at best lessen the attacks’ frequency. Chenko suspects the deeper fault lies not in production but in the molecular mechanism that releases neurotransmitters from their reservoirs.

The alternative is an experimental array installed permanently beneath Miles’s skull. Feedback sensors would report when the reservoirs were becoming dangerously overloaded, allowing him to use a neural stimulator to trigger a seizure at a chosen time and place. If scheduled, the attacks should be milder and shorter. Proper monitoring might also allow him to drive or fly, though Chenko presents that possibility conditionally, not as a guarantee. The proposal does not promise restoration to an untouched state; it offers a means of managing an unpredictable process by making it deliberate.

Miles asks whether he might otherwise have the attacks for the rest of his life. Chenko cannot say: the condition is unique in his experience. Miles nevertheless agrees to try the device. That decision marks a shift from waiting for a cure to accepting an uncertain method of control. It also leaves intact the questions the diagnosis cannot answer: whether he will regain the freedom to travel and serve, and whether medical recovery could repair the professional separation from ImpSec. The disorder is both an identifiable neurological mechanism and a continuing limit on what Miles can safely choose.